RecruitingNCT06849635

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

Cera™ ASD Occluder Post-Market Clinical Follow-Up Study：A Multi-Center, Single-arm, Ambispective Post-Market Follow-Up Study

Sponsor

Lifetech Scientific (Shenzhen) Co., Ltd.

Enrollment

139 participants

Start Date

Jan 3, 2025

Study Type

OBSERVATIONAL

Conditions

Atrial Septal Defect

Summary

The objective of this post-market study is to: * collect real-word clinical data and confirm the long-time safety and performance of the Lifetech Cera™ ASD Occluder * identify previously unknown side-effects

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with atrial septal defect. The study is currently recruiting participants at 6 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(6)

G.V.M.Carint Hospital

Myszków, Poland

Centre for Invasive Cardiology, Electrotherapy and Angiology G.V.M.Carint-Oswiecim

Oświęcim, Poland

Subcarpathian Centre for Cardiovascular Intervention G.V.M.Carint -Sanok

Sanok, Poland

Polish-American Heart Clinics, Heart and Vascular Center in Tychy, American Heart of Poland Group

Tychy, Poland

Polish-American Heart Clinics 1st Department of Invasive Cardiology and Heart Failure in Ustroń, AHoP Group

Ustroń, Poland

Dr. Tytus Chałubiński County Hospital

Zakopane, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06849635

Related Trials

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

NCT058877005 locations

Cerebral Microembolization Associated With PFO Closure

NCT063472761 location

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

NCT020977581 location